Analyzing the disparity between youth and adult HPV uptake
Human papillomavirus (HPV) is the most common sexually transmitted infection worldwide and can cause various types of cancer.…
New guidance aims to standardize tumor mutational burden in cancer
Immune checkpoint inhibitors have transformed cancer care, yet only a minority of patients respond to monotherapy, and immune-related…
Blood pressure drug boosts effectiveness of cancer therapy
In a new Dartmouth Cancer Center (DCC) study led by clinical researcher Tyler J. Curiel, MD, MPH, FACP,…
Detailed cell atlas reveals earliest changes in prostate cancer
Prostate cancer affects one in five Australian men, making it the most common cancer in the country. Now,…
Systematic review identifies stress-induced biological triggers in oncology
Stress is a constant companion in the oncologist’s office. It appears at the time of diagnosis, increases with…
Microscopic sensors could revolutionize diagnosis and monitoring of cancer
Microscopic sensors that are as thin as a strand of hair but capable of taking multiple measurements simultaneously could revolutionize the diagnosis and…
BNP predicts kidney disease progression risk in diabetes patients
The relationship between cardiovascular dysfunction and renal impairment is widely recognized as the cardiorenal interaction, a complex physiological…
Webinar introduces advanced bioinformatics tool to interpret mutations in cancer genomes
A free open-access webinar will introduce the Cancer Genome Interpreter (CGI), an advanced bioinformatics tool to interpret mutations…
Lab-grown food pipe offers hope for children with esophageal conditions
Scientists from Great Ormond Street Hospital (GOSH) and University College London (UCL) have created the first lab‑grown esophagus…
Novartis agrees to acquire a pan-mutant-selective PI3Kα inhibitor, strengthening its breast cancer pipeline
Proposed acquisition supports the Novartis oncology strategy in hormone receptor positive, human epidermal growth factor receptor two-negative (HR+/HER2-)…
Abbott closing Exact Sciences acquisition next week | News
MADISON, Wis. — Abbott expects to close its acquisition of Exact Sciences on Monday, the healthcare giant said.…
Cancer deaths fall to historic low in UK – this is probably why
The latest stats on cancer death rates in the UK offer encouraging news – and further progress against…